ARQT – arcutis biotherapeutics, inc. - common stock (US:NASDAQ)
Stock Stats
News
Arcutis Biotherapeutics: Behind The Big Rally [Seeking Alpha]
Arcutis Biotherapeutics (NASDAQ:ARQT) was given a new $37.00 price target on by analysts at Mizuho.
Tori Spelling And Daughter Stella Open Up About Struggles With Eczema [Forbes]
FDA Accepts Supplemental New Drug Application for Arcutis’ ZORYVE® (roflumilast) Cream 0.3% for the Treatment of Plaque Psoriasis in Children Ages 2 to 5
Arcutis Completes Enrollment in INTEGUMENT-INFANT Phase 2 Study Evaluating ZORYVE® (roflumilast) Cream 0.05% in Infants with Atopic Dermatitis [Yahoo! Finance]
Form 4 Arcutis Biotherapeutics, For: Dec 01 Filed by: Matsuda Masaru
Form 4 Arcutis Biotherapeutics, For: Dec 01 Filed by: Welgus Howard G.
Form 144 Arcutis Biotherapeutics, Filed by: Welgus Howard G.
Form 144 Arcutis Biotherapeutics, Filed by: Matsuda Masaru
Form 4 Arcutis Biotherapeutics, For: Nov 24 Filed by: LIN SUE-JEAN
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.